HomeSNY • NASDAQ
Sanofi SA
$57.12
Sep 27, 9:30:25 AM GMT-4 · USD · NASDAQ · Disclaimer
US listed securityFR headquartered
Previous close
$57.00
Day range
$57.12 - $57.16
Year range
$42.63 - $58.97
Market cap
144.82B USD
Avg Volume
1.58M
CDP Climate Change Score
A-
Financials
Income Statement
Revenue
Net income
(EUR)Jun 2024Y/Y change
Revenue
11.38B7.48%
Operating expense
6.36B10.07%
Net income
1.11B-22.44%
Net profit margin
9.78-27.82%
Earnings per share
0.94-2.13%
EBITDA
2.51B2.14%
Effective tax rate
21.12%
Total assets
Total liabilities
(EUR)Jun 2024Y/Y change
Cash and short-term investments
6.80B-14.99%
Total assets
129.76B3.51%
Total liabilities
56.76B8.30%
Total equity
73.00B
Shares outstanding
1.25B
Price to book
0.98
Return on assets
Return on capital
4.29%
Net change in cash
(EUR)Jun 2024Y/Y change
Net income
1.11B-22.44%
Cash from operations
Cash from investing
Cash from financing
Net change in cash
Free cash flow
About
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89. Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. Wikipedia
Founded
1973
Website
Employees
86,088
Search
Clear search
Close search
Google apps
Main menu